122 results
Page 3 of 7
8-K
EX-99.2
36h64t1wg s78al7c
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
12j9z08iey0w8f
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K
EX-99.2
e7pu3ipnp1r0
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
h2g50e
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
etaghmoy
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.3
qmpz00s
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
cevb9og79uoc 1m9ng
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
z0equqw ly
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
ziwpk1 9o1w51
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
9szzbxey5xt6 s65jvrk
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
jsg2dq1p n3u92t48
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-10.1
pr3rgds7
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.3
5ly wtfseiwhuimwq31
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
3fymwxbfsm5u46xsawr
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm